Tuesday, July 04, 2023 12:51:32 PM
A break DOWN of $0.50 will likely visit a NEW (more accelerated & precipitous) DROP!! Consult a chart. The DILUTION being visited upon this stock is getting to be a BIT ridiculous -- even for a BIO Pharma!
Linda Powers and Les Goldman have a CASH BURN rate that belies the shareholders ability to SUPPORT. Not to mention OUTPACE the presumed upside, which is A WAAAAYS away! Been a GREAT SHORT since last years' spike to $1 PLUS & the price recovered from COVERING (imho), only to be SHORTED AGAIN as the DILUTION continues at an unsustainable RATE (lately).
Problem is the LOWER this goes THE MORE SHARES they have to PUNT!! Get those two to STOP & maybe shareholders have a shot. Otherwise, wait for the covering LOWER -- get them to STOP issuing (at this rate) & maybe a DIFFERENT conversation may be had! https://www.otcmarkets.com/stock/NWBO/security
I give them 9-24mos before they RAISE the AS -- again! Problem is there is NOTHING to bolster the balance sheet into that EARLIER time-frame to forestall (or slow the rate). Let's see a RABBIT!
Linda Powers and Les Goldman have a CASH BURN rate that belies the shareholders ability to SUPPORT. Not to mention OUTPACE the presumed upside, which is A WAAAAYS away! Been a GREAT SHORT since last years' spike to $1 PLUS & the price recovered from COVERING (imho), only to be SHORTED AGAIN as the DILUTION continues at an unsustainable RATE (lately).
Problem is the LOWER this goes THE MORE SHARES they have to PUNT!! Get those two to STOP & maybe shareholders have a shot. Otherwise, wait for the covering LOWER -- get them to STOP issuing (at this rate) & maybe a DIFFERENT conversation may be had! https://www.otcmarkets.com/stock/NWBO/security
I give them 9-24mos before they RAISE the AS -- again! Problem is there is NOTHING to bolster the balance sheet into that EARLIER time-frame to forestall (or slow the rate). Let's see a RABBIT!
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
